Dr Alba Women's Health Ltd 16173097 true 2025-01-09 2026-01-31 2026-01-31 The principal activity of the company is that of medical services relating to menopause. Digita Accounts Production Advanced 6.30.9574.0 true Alba Lupia Soares Pereira Ian Peter Haslegrave true 16173097 2025-01-09 2026-01-31 16173097 2026-01-31 16173097 bus:OrdinaryShareClass1 2026-01-31 16173097 core:ShareCapital 2026-01-31 16173097 bus:FRS102 2025-01-09 2026-01-31 16173097 bus:AuditExempt-NoAccountantsReport 2025-01-09 2026-01-31 16173097 bus:FullAccounts 2025-01-09 2026-01-31 16173097 bus:RegisteredOffice 2025-01-09 2026-01-31 16173097 bus:Director1 2025-01-09 2026-01-31 16173097 bus:Director2 2025-01-09 2026-01-31 16173097 bus:OrdinaryShareClass1 2025-01-09 2026-01-31 16173097 bus:EntityHasNeverTraded 2025-01-09 2026-01-31 16173097 bus:PrivateLimitedCompanyLtd 2025-01-09 2026-01-31 16173097 countries:EnglandWales 2025-01-09 2026-01-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 16173097

Dr Alba Women's Health Ltd

Unaudited Filleted Financial Statements

for the Period from 9 January 2025 to 31 January 2026

 

Dr Alba Women's Health Ltd

(Registration number: 16173097)
Balance Sheet as at 31 January 2026

Note

2026
£

Current assets

 

Cash at bank and in hand

 

2

Capital and reserves

 

Called up share capital

3

2

Shareholders' funds

 

2

For the financial period ending 31 January 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 24 June 2026 and signed on its behalf by:
 

.........................................
Alba Lupia Soares Pereira
Director

 

Dr Alba Women's Health Ltd

Notes to the Unaudited Financial Statements for the Period from 9 January 2025 to 31 January 2026

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
30 Parfrey Street
London
W6 9EN
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Share capital

Allotted, called up and fully paid shares

2026

No.

£

Ordinary shares of £1 each

2

2